Growth hormone response to apomorphine and diagnosis

A comparison of three diagnostic systems

Jack Hirschowitz, Frank P. Zemlan, Robert Hitzemann, Roberta L. Fleischmann, David L. Garver

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Our study takes a further look at the apomorphine test in the psychoses and affective disorders, with special reference to the use of different diagnostic systems. Patients meeting Research Diagnostic Criteria (RDC) for schizophrenia, schizoaffective disorder, or manic disorder were included. In addition to the RDC, diagnosis was also made using the DSM-III and ICD-9. All patients underwent an evaluation of peak GH response to apomorphine administration. The results show that RDC and ICD-9 are similar, in that for both systems, a high GH response correlates with a schizoaffective disorder and distinguishes those patients significantly from manic patients. The DMS-III brings in some new dimensions, in that schizophreniform disorder (6-month cut-off) is distinguished from schizophrenia. In addition, patients with affective symptoms and mood-incongruent psychoses are more closely related to schizophreniform disorder than to classical manic disorder.

Original languageEnglish (US)
Pages (from-to)445-454
Number of pages10
JournalBiological Psychiatry
Volume21
Issue number5-6
DOIs
StatePublished - 1986
Externally publishedYes

Fingerprint

Apomorphine
Psychotic Disorders
Growth Hormone
International Classification of Diseases
Bipolar Disorder
Schizophrenia
Research
Affective Symptoms
Mood Disorders
Diagnostic and Statistical Manual of Mental Disorders

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Growth hormone response to apomorphine and diagnosis : A comparison of three diagnostic systems. / Hirschowitz, Jack; Zemlan, Frank P.; Hitzemann, Robert; Fleischmann, Roberta L.; Garver, David L.

In: Biological Psychiatry, Vol. 21, No. 5-6, 1986, p. 445-454.

Research output: Contribution to journalArticle

Hirschowitz, Jack ; Zemlan, Frank P. ; Hitzemann, Robert ; Fleischmann, Roberta L. ; Garver, David L. / Growth hormone response to apomorphine and diagnosis : A comparison of three diagnostic systems. In: Biological Psychiatry. 1986 ; Vol. 21, No. 5-6. pp. 445-454.
@article{72dd4c2670174347a0f0e89181013032,
title = "Growth hormone response to apomorphine and diagnosis: A comparison of three diagnostic systems",
abstract = "Our study takes a further look at the apomorphine test in the psychoses and affective disorders, with special reference to the use of different diagnostic systems. Patients meeting Research Diagnostic Criteria (RDC) for schizophrenia, schizoaffective disorder, or manic disorder were included. In addition to the RDC, diagnosis was also made using the DSM-III and ICD-9. All patients underwent an evaluation of peak GH response to apomorphine administration. The results show that RDC and ICD-9 are similar, in that for both systems, a high GH response correlates with a schizoaffective disorder and distinguishes those patients significantly from manic patients. The DMS-III brings in some new dimensions, in that schizophreniform disorder (6-month cut-off) is distinguished from schizophrenia. In addition, patients with affective symptoms and mood-incongruent psychoses are more closely related to schizophreniform disorder than to classical manic disorder.",
author = "Jack Hirschowitz and Zemlan, {Frank P.} and Robert Hitzemann and Fleischmann, {Roberta L.} and Garver, {David L.}",
year = "1986",
doi = "10.1016/0006-3223(86)90186-1",
language = "English (US)",
volume = "21",
pages = "445--454",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "5-6",

}

TY - JOUR

T1 - Growth hormone response to apomorphine and diagnosis

T2 - A comparison of three diagnostic systems

AU - Hirschowitz, Jack

AU - Zemlan, Frank P.

AU - Hitzemann, Robert

AU - Fleischmann, Roberta L.

AU - Garver, David L.

PY - 1986

Y1 - 1986

N2 - Our study takes a further look at the apomorphine test in the psychoses and affective disorders, with special reference to the use of different diagnostic systems. Patients meeting Research Diagnostic Criteria (RDC) for schizophrenia, schizoaffective disorder, or manic disorder were included. In addition to the RDC, diagnosis was also made using the DSM-III and ICD-9. All patients underwent an evaluation of peak GH response to apomorphine administration. The results show that RDC and ICD-9 are similar, in that for both systems, a high GH response correlates with a schizoaffective disorder and distinguishes those patients significantly from manic patients. The DMS-III brings in some new dimensions, in that schizophreniform disorder (6-month cut-off) is distinguished from schizophrenia. In addition, patients with affective symptoms and mood-incongruent psychoses are more closely related to schizophreniform disorder than to classical manic disorder.

AB - Our study takes a further look at the apomorphine test in the psychoses and affective disorders, with special reference to the use of different diagnostic systems. Patients meeting Research Diagnostic Criteria (RDC) for schizophrenia, schizoaffective disorder, or manic disorder were included. In addition to the RDC, diagnosis was also made using the DSM-III and ICD-9. All patients underwent an evaluation of peak GH response to apomorphine administration. The results show that RDC and ICD-9 are similar, in that for both systems, a high GH response correlates with a schizoaffective disorder and distinguishes those patients significantly from manic patients. The DMS-III brings in some new dimensions, in that schizophreniform disorder (6-month cut-off) is distinguished from schizophrenia. In addition, patients with affective symptoms and mood-incongruent psychoses are more closely related to schizophreniform disorder than to classical manic disorder.

UR - http://www.scopus.com/inward/record.url?scp=0022919263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022919263&partnerID=8YFLogxK

U2 - 10.1016/0006-3223(86)90186-1

DO - 10.1016/0006-3223(86)90186-1

M3 - Article

VL - 21

SP - 445

EP - 454

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 5-6

ER -